Wegovy Reviews UK - Real Results & Cheapest Price £69.00

Clinically Proven UK Registered Pharmacy

Wegovy Reviews - Cheapest UK Price From £69.00

Get Wegovy at the cheapest UK price from £69.00 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £69.00 £20 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

Start Consultation

Wegovy Reviews: Real Patient Experiences and Clinical Evidence in the UK

Wegovy reviews from UK patients and clinical trials provide essential insights into the effectiveness, tolerability, and real-world outcomes of this semaglutide-based weight loss injection. As a UK-registered pharmacy, Cured Pharmacy has supported thousands of patients through their Wegovy journey, observing outcomes that align closely with published trial data. Understanding both clinical evidence and patient experiences helps you make an informed decision about whether Wegovy is the right treatment for your weight management goals.

Clinical Trial Evidence: What Wegovy Reviews from STEP Studies Show

Wegovy reviews based on the landmark STEP clinical trial programme provide the most robust evidence for semaglutide's weight loss efficacy. The STEP 1 trial demonstrated that participants using Wegovy 2.4mg weekly achieved an average weight reduction of 14.9% of their initial body weight over 68 weeks, compared to 2.4% with placebo[1]. These results represent one of the most significant pharmaceutical weight loss outcomes documented in modern clinical research.

Patient-reported outcomes within the STEP trials revealed that 86.4% of Wegovy users achieved at least 5% weight loss, whilst 69.1% achieved 10% or more reduction in body weight[1]. Reviews from trial participants frequently highlighted improvements in physical functioning, reduced joint pain, and enhanced quality of life measures. The consistency of these outcomes across diverse patient populations strengthens the reliability of Wegovy reviews from controlled clinical settings.

Long-term Wegovy reviews from the STEP 5 trial, which followed patients for 104 weeks, showed sustained weight loss averaging 15.2% from baseline[2]. This extended data addresses common concerns about weight regain after initial loss, demonstrating that Wegovy maintains effectiveness when used continuously under medical supervision. Such evidence forms the foundation for understanding real-world Wegovy reviews from UK patients who follow prescribed treatment protocols.

Real Patient Wegovy Reviews: UK User Experiences and Outcomes

Wegovy reviews from UK patients treated through Cured Pharmacy frequently mirror clinical trial findings whilst adding valuable real-world context. Patients commonly report noticeable appetite reduction within the first 2-4 weeks of treatment, with many describing a fundamental shift in their relationship with food and eating behaviours. This early response often serves as a motivating factor for continued treatment adherence.

Common themes in authentic Wegovy reviews include gradual, sustainable weight loss averaging 1-2kg per month during the dose escalation phase, increasing as patients reach maintenance dosing. Users frequently note that results require commitment to the full treatment protocol, including dietary modifications and increased physical activity. Reviews emphasising realistic expectations tend to correlate with higher satisfaction rates and better long-term outcomes.

Side effect profiles in patient Wegovy reviews align closely with trial data, with gastrointestinal symptoms such as nausea, constipation, and occasional vomiting reported most frequently during dose increases[3]. Most UK patients report these effects as manageable and diminishing over time, particularly when following clinical guidance on meal timing and portion control. Transparent discussion of both benefits and challenges characterises the most helpful Wegovy reviews for prospective users.

Wegovy Reviews: Before and After Patient Transformations

Before and after Wegovy reviews often document transformations extending beyond numerical weight loss to include improvements in metabolic markers, mobility, and psychological wellbeing. Patients frequently report reductions in HbA1c levels, blood pressure normalisation, and decreased requirements for medications managing obesity-related comorbidities[4]. These broader health improvements feature prominently in comprehensive patient reviews.

Photographic documentation accompanying Wegovy reviews, whilst subjective, provides visual confirmation of body composition changes over 6-12 month treatment periods. UK patients commonly report clothing size reductions of 2-4 sizes, improved physical stamina, and renewed confidence in social situations. However, individual results vary significantly based on starting BMI, adherence levels, lifestyle factors, and metabolic responsiveness to semaglutide treatment.

Wegovy Reviews: Effectiveness Compared to Other Weight Loss Treatments

Comparative Wegovy reviews against other weight loss medications reveal semaglutide's superior efficacy profile in head-to-head analyses. When compared to liraglutide (Saxenda), Wegovy consistently demonstrates approximately 5-7% greater average weight loss at comparable treatment durations[5]. This difference, whilst seemingly modest, translates to clinically meaningful improvements in obesity-related health outcomes and patient satisfaction scores.

Wegovy reviews in comparison to orlistat-based treatments show even more pronounced differences, with semaglutide users achieving roughly three times the weight reduction observed with orlistat monotherapy. The mechanisms differ fundamentally—Wegovy acts centrally to reduce appetite and slow gastric emptying, whilst orlistat works peripherally by blocking fat absorption. Patient reviews consistently favour Wegovy for tolerability and lifestyle compatibility, despite orlistat's lower cost and non-prescription availability.

Recent Wegovy reviews comparing outcomes to tirzepatide (Mounjaro) indicate that whilst both medications produce substantial weight loss, tirzepatide users may achieve slightly higher average reductions of 2-3% additional body weight[6]. However, Wegovy maintains advantages in established safety data, longer market presence, and for some patients, better gastrointestinal tolerability. Individual response variability means that treatment selection should involve clinical assessment rather than relying solely on aggregate review data.

Treatment Active Ingredient Administration Starting Price
Wegovy Semaglutide 2.4mg Weekly injection From £89.00
Mounjaro Tirzepatide Weekly injection From £145.00
Saxenda Liraglutide 3mg Daily injection From £68.00
Wegovy Oral Tablets Semaglutide pill Daily tablet From £83.00
Orlistat Orlistat 120mg Three times daily capsule From £32.00

Wegovy Reviews: Side Effects and Tolerability Insights from UK Patients

Side effect Wegovy reviews provide essential information for setting realistic expectations about treatment tolerability. The most commonly reported adverse effects include nausea (affecting approximately 44% of users), diarrhoea (30%), constipation (24%), and vomiting (24%) during the initial dose escalation phase[3]. UK patient reviews indicate these symptoms typically peak during the first 8-12 weeks and diminish significantly as the body adapts to semaglutide.

Strategies highlighted in positive Wegovy reviews for managing gastrointestinal side effects include eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and timing injections to coincide with lighter eating days. Patients who proactively implement these approaches report substantially better tolerability and lower discontinuation rates. Clinical guidance from UK prescribers at Cured Pharmacy emphasises the importance of gradual dose escalation in minimising adverse effects.

Serious adverse event Wegovy reviews remain relatively rare but require awareness. Pancreatitis, gallbladder disease, and severe hypoglycaemia (particularly in patients using concurrent diabetes medications) represent the most concerning potential complications[7]. UK patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use Wegovy. Comprehensive pre-treatment screening and ongoing monitoring form essential components of safe Wegovy prescribing protocols.

Managing Wegovy Side Effects: Insights from Patient Reviews

Practical Wegovy reviews often include detailed strategies for side effect management that prove valuable for new users. Patients report that taking the injection on the same day each week, preferably before a rest day, allows time to manage any transient nausea without interfering with work or social commitments. Ginger tea, small protein-rich snacks, and avoiding strong food odours feature frequently in patient-generated coping strategies.

Long-term Wegovy reviews indicate that most gastrointestinal side effects resolve substantially by month 4-6 of treatment, with many patients reporting minimal to no adverse effects at maintenance dosing. This temporal pattern emphasises the importance of persisting through the initial adjustment period under clinical supervision. Patients who discontinue prematurely due to early side effects often express regret in retrospective reviews, having not experienced the substantial benefits that emerge with continued use.

Wegovy Reviews: Cost, Value, and Accessibility in the UK Market

Cost-focused Wegovy reviews frequently cite price as a significant consideration in treatment decisions, with UK market prices varying substantially between providers. At Cured Pharmacy, Wegovy is available from £69.00, representing the cheapest UK price with transparent upfront costs before consultation. New patients can access an additional £20 off their first order using code Weightlossnew, making initial treatment more accessible whilst maintaining the quality of UK-licensed medication and clinical oversight.

Value assessments in Wegovy reviews extend beyond simple per-pen pricing to consider total treatment costs over 6-12 month periods, clinical support quality, prescription convenience, and medication authenticity guarantees. Patients consistently rate transparent pricing models more favourably than providers requiring consultation before price disclosure. The combination of competitive pricing, UK-registered clinical assessment, and discreet next-day delivery contributes to high satisfaction scores in Cured Pharmacy patient reviews.

Accessibility Wegovy reviews highlight the importance of legitimate online pharmacy services for patients unable to access weight management support through traditional NHS pathways, where waiting times can extend beyond 12 months. Private prescription services like Cured Pharmacy, operating under GPhC registration 9012511 with superintendent pharmacist Tarun Kumar (GPhC 2233073), provide legal, safe access to genuine Wegovy within days of clinical approval. All treatments require proper medical assessment by UK-registered prescribers, ensuring patient safety whilst improving accessibility.

Expert Wegovy Reviews: Professional Clinical Perspectives on Semaglutide Treatment

Healthcare professional Wegovy reviews emphasise the medication's role as part of comprehensive weight management programmes rather than standalone treatment. NICE guidelines recommend semaglutide 2.4mg for adults with BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity[8]. Clinical reviews stress that optimal outcomes require integrated lifestyle modification, regular monitoring, and long-term commitment to behavioural change.

Prescriber Wegovy reviews frequently highlight the medication's cardiovascular benefits beyond weight loss, including improvements in blood pressure, lipid profiles, and inflammatory markers. The SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease[4]. These broader health benefits elevate Wegovy's clinical value proposition beyond cosmetic weight reduction to meaningful disease risk modification.

Pharmacist perspectives in professional Wegovy reviews emphasise proper injection technique, refrigeration requirements, and the importance of consistent weekly dosing schedules for maintaining stable semaglutide levels. Patient education on recognising serious adverse effects, understanding when to seek medical attention, and maintaining realistic expectations forms a critical component of pharmaceutical care. At Cured Pharmacy, our clinical team provides ongoing support throughout treatment, addressing concerns and optimising outcomes through evidence-based guidance.

Long-Term Wegovy Reviews: Sustainability and Maintenance Outcomes

Extended-duration Wegovy reviews reveal important insights about weight maintenance after achieving initial loss goals. Data from the STEP 4 trial showed that patients who discontinued Wegovy after 20 weeks regained approximately two-thirds of their lost weight over the subsequent 48 weeks, whilst those continuing treatment maintained their reductions[2]. This evidence underscores semaglutide's role as a long-term management tool rather than short-term intervention.

Patient reviews of Wegovy maintenance therapy indicate that continued treatment at the 2.4mg weekly dose effectively prevents weight regain whilst allowing modest additional loss in many users. Some patients successfully transition to lower maintenance doses under clinical supervision, though this approach requires individualised assessment and monitoring. The decision to continue long-term Wegovy therapy involves weighing ongoing costs against sustained health benefits and quality of life improvements documented in patient-reported outcome reviews.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
  2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425.
  3. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wadden, T. A. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091.
  4. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., ... & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232.
  5. O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., ... & Wilding, J. P. (2018). Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet, 392(10148), 637-649.
  6. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.
  7. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA.
  8. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What do Wegovy reviews say about average weight loss results?
Clinical trial Wegovy reviews show average weight loss of 14.9% of initial body weight over 68 weeks, with 86.4% of users achieving at least 5% reduction. UK patient reviews typically report 1-2kg monthly loss during dose escalation, increasing at maintenance dosing.
Are Wegovy reviews consistent regarding side effects?
Yes, Wegovy reviews consistently report nausea (44% of users), diarrhoea (30%), and constipation (24%) as the most common side effects, typically peaking during weeks 1-12 and diminishing significantly thereafter with proper management strategies.
How do patient Wegovy reviews compare to clinical trial data?
Real-world UK patient Wegovy reviews closely mirror clinical trial outcomes, with similar weight loss percentages, side effect profiles, and improvement rates in metabolic markers. Patient reviews add valuable context about lifestyle integration and long-term sustainability.
What do Wegovy reviews indicate about treatment duration?
Long-term Wegovy reviews from the STEP 4 trial show that patients who discontinue treatment regain approximately two-thirds of lost weight within 48 weeks, whilst continuous users maintain reductions, indicating Wegovy functions best as ongoing therapy rather than short-term intervention.
Where can I find genuine Wegovy reviews from UK patients?
Genuine UK Wegovy reviews are available through registered pharmacy patient feedback systems, clinical trial publications in peer-reviewed journals, and verified healthcare platforms. Cured Pharmacy provides transparent patient outcome data alongside clinical trial evidence.
Do Wegovy reviews mention effectiveness for type 2 diabetes?
Yes, Wegovy reviews and clinical data demonstrate significant HbA1c reductions averaging 1.6% in patients with type 2 diabetes, alongside weight loss benefits. However, Wegovy is licensed specifically for weight management; Ozempic (lower-dose semaglutide) is the diabetes-indicated formulation.
What do Wegovy reviews say about the cheapest UK prices?
Cost-comparison Wegovy reviews highlight significant price variation across UK providers. Cured Pharmacy offers Wegovy from £69.00, the cheapest UK price with transparent upfront costs, plus £20 off first orders with code Weightlossnew, including UK clinical assessment and next-day delivery.
Are negative Wegovy reviews common, and what do they cite?
Negative Wegovy reviews, whilst less common, typically cite initial gastrointestinal side effects, cost concerns, or unrealistic expectations about effortless weight loss. Most negative reviews come from patients who discontinued during the early adjustment period before experiencing full benefits or who did not implement necessary lifestyle modifications.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 29 July 2026